Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131

This information is intended for Colorado Prescribers 

HB 19-1131

MARKETED PRESCRIPTION DRUG COLORADO WAC DISCLOSURE FORM DATE UPDATED
Diabetes Products Form 1/17/2020
Vaccines Form 1/01/2021
ALDURAZYME® (laronidase) Form 1/22/2020
ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein] Form 1/17/2020
AUBAGIO® (teriflunomide) Form 1/17/2020
CABLIVI® (caplacizumab-yhdp) Form 1/17/2020
CERDELGA® (eliglustat) capsules, for oral use Form 1/17/2020
Cerezyme® (imiglucerase for injection) Form 1/17/2020
DUPIXENT® (dupilumab) Injection Form 7/01/2020
ELITEK® (rasburicase) for injection Form 7/01/2020
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] Form 1/17/2020
FABRAZYME® (agalsidase beta) for injection, for intravenous use Form 1/17/2020
JEVTANA® (cabazitaxel) Injection Form 7/01/2020
KEVZARA® (sarilumab) Form 1/17/2020
LEMTRADA® (alemtuzumab) Form 7/01/2020
LIBTAYO® (cemiplimab - rwlc) Form 1/17/2020
LOVENOX® (enoxaparin sodium injection)  Form  
LUMIZYME® (alglucosidase alfa) Form 1/17/2020
Mozobil® (plerixafor injection) Form 1/17/2020
MULTAQ® (dronedarone) Form 1/17/2020
SARCLISA® (isatuximab-irfc) injection Form 3/09/2020
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] Form 1/17/2020
THYROGEN® (thyrotropin alfa for injection) Form 1/17/2020

. Published by the General Assembly of the State of Colorado  

Please See Full Prescribing Information, including Boxed Warning, for , , , , , , , , ,